Italy's artificial intelligence (AI) in medical Imaging market size was valued at $36 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 34.9% from 2022 to 2030 and will reach $395 Mn. The market is segmented by AI technology, solution, modality, application, and end User. Due to developments in AI and machine learning algorithms that are enabling the creation of more precise and effective medical imaging software, the Italy Artificial Intelligence (AI) in the Medical Imaging market will expand. Some of the key players in this market are Canon Medical Systems, Barco, Medtronic, GE Healthcare, Siemens Healthineers, Hologic, Koninklijke Philips, Fujifilm, Brainomix, Quibim, and others.
By 2030, it is anticipated that the Hong Kong Nutrition and Supplements market will reach a value of $1.26 Bn from $0.61 Bn in 2022, growing at a CAGR of 9.5% during 2022-2030. The market is primarily dominated by local players such as Vita Green Health, Eu Yan Sang International Limit, and RightEA Trading. The market for nutrition and supplements in Hong Kong is primarily driven by government initiatives, increasing consumer awareness of health and lifestyle, and strict government regulations. The Hong Kong nutrition and supplements market in Hong Kong is segmented by Type, Product, application, and Distribution Channel.
Canada's clinical diagnostics is expected to witness significant growth from $3.9 Bn in 2022 to $4.9 Bn in 2030 with a CAGR of 3.1% for the year 2022-30. The main growth drivers of the Canadian clinical diagnostics market are growing awareness about early disease detection and the benefits of early treatment. Further, the increasing investments by the government in diagnostic services are responsible for the market growth. The market is segmented by molecular diagnostics and end users. LifeLabs, SickKids, and Dynacare are some of the top players in this market.
This report presents a strategic analysis of the Hong Kong Pharmaceutical Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Hong Kong Pharmaceutical Market, offering unmatched value, accuracy and expert insights.
By 2030, it is anticipated that the Vietnam Lung Cancer Therapeutics Market will reach a value of $283 Mn from $149 Mn in 2022, growing at a CAGR of 8.3% during 2022-30. The Lung Cancer Therapeutics Market in Vietnam is dominated by a few domestic pharmaceutical companies such as Hau Giang Pharmaceutical, Traphaco, and Vietnam Pharmaceutical. The Lung Cancer Therapeutics Market in Vietnam is segmented into different types of cancer and different therapy types. Some of the major factors affecting the Vietnam lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies, and the presence of highly efficient drugs.
The US Retail Pharmacy Market is projected to grow from $436.2 Bn in 2022 to $639.6 Bn by 2030, registering a CAGR of 4.9% during the forecast period of 2022 - 2030. The growing demand for convenience in healthcare is driving the retail pharmacy market as more people are looking for ways to easily access and manage their medications. There are some of the major companies operating in the US Retail Pharmacy Market include CVS Health, Walgreens Boots Alliance, Rite Aid, and Walmart.
By 2030, it is anticipated that the US HIV therapeutics market will reach a value of $6.36 Bn from $5.78 Bn in 2022, growing at a CAGR of 1.2% during 2022-2030. The market is primarily dominated by local players such as ViiV Healthcare, Merck & Co, and Bristol-Myers Squibb. The market is driven by innovation in research and development, increasing prevalence, and good governance. The HIV therapeutics market in the US is segmented by type, product, geography, end user, and distribution channel.
UK Acute Myeloid Leukemia Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023-30. The ageing population, higher drug approval rates, the designation of acute myeloid leukaemia as an orphan disease, and rising healthcare costs are anticipated to drive the market. One of the factors accelerating the market's growth is the technological advancement made possible by the capacity to recognise damaged cells. Major global players in Acute Myeloid Leukemia Market are Ambit Biosciences Corporation, Genzyme Corporation, Celgene Corporation, Clavis Pharma ASA, Sunesis Pharmaceuticals, Cephalon, Bristol-Myers Squibb, Novartis International AG, GlaxoSmithKline.
The UAE home healthcare market was valued at $1.83 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 8.93% from 2022 to 2030 and will reach $3.59 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, many insurances now include home healthcare. The market is segmented by equipment outlook and by services. Some key players in this market are Omega Home Health Care, Ishraq home healthcare, bayti Home Healthcare, Manzil, Mediclinic, NMC Health, and Alleanza.
This report presents a strategic analysis of Turkey's Advanced Therapy Medicinal Products (ATMPs) Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about Turkey's Advanced Therapy Medicinal Products (ATMPs) Market, offering unmatched value, accuracy, and expert insights.
South Korean cancer immunotherapy market is expected to grow from $1.64 Bn in 2022 to $3.06 Bn in 2030 with a CAGR of 8.1% for the forecasted year 2022-30. The increase in the ageing population and the demand for new and innovative treatment options in South Korea have led to the growth of the market. The South Korean cancer immunotherapy market is segmented by type, application, and end user. Selecxine, Panolos Bioscience, and Bayer are the major players in the South Korean cancer immunotherapy market.
Saudi Arabia's Palliative care market is projected to grow from $222.36 Mn in 2022 to $459.59 Mn by 2030, registering a CAGR of 9.5% during the forecast period of 2022-30. The main factors driving the growth would be an increasing aging population, a rise in the prevalence of chronic diseases, and government support. The market is segmented by service type and by the end user. Some of the major players include King Fahad Medical City, King Faisal Specialist Hospital, and Research Center, Salam Medical, and others.